U.S. Energy Services Stock News

In its latest quarterly report, Palomar Holdings, a specialty insurer focused on catastrophe markets such as earthquake coverage, delivered revenue that exceeded analyst expectations. This stronger-than-expected top line performance has drawn renewed market attention to how Palomar’s catastrophe-focused business model is responding to current insurance demand trends. With revenue surpassing analyst forecasts, we’ll now examine how this earnings surprise may influence Palomar’s investment...

PC Connection has been named Zebra Technologies' 2025 Partner of the Year for National Solutions Providers. The award recognizes PC Connection's role in expanding Zebra's solutions and services across its channel network. This partnership focus centers on Zebra Technologies (NasdaqGS:ZBRA), a supplier of data capture, automation, and enterprise technology. Zebra Technologies, traded as NasdaqGS:ZBRA, sells hardware, software, and services that support barcode scanning, RFID, mobile...

Rayonier has announced that Ashlee Townsend Cribb resigned earlier this month as Executive Vice President, Wood Products, effective March 20, 2026, with veteran operations leader Ryan M. Daniels stepping in as Interim Senior Vice President while the company conducts a broader search. This leadership change places a long-tenured wood products operator at the helm during an important period for integrating the recently merged wood products platform and managing operational execution. Next,...

If you are wondering whether ACM Research at around US$43.55 is still attractively priced after its recent run, this article walks through what the current market price may be implying about the stock. The share price has seen a 6.1% decline over the past week and a 32.6% decline over the past month, while still sitting on a 62.1% return over the last year and a very large 3 year gain alongside a 56.7% return over 5 years, which can change how investors think about both upside and...

Structure Therapeutics (GPCR) has drawn investor attention after recent share price volatility, with the stock closing at US$48.59 and showing sizable moves over the past month and over the past three months. See our latest analysis for Structure Therapeutics. Those recent share price moves come after a sharp pullback. The 30 day share price return shows a 28.92% decline and the 90 day share price return shows a 25.18% decline, while the 1 year total shareholder return remains very large at...

Western Alliance Bank, part of Western Alliance Bancorporation (NYSE:WAL), has launched a new veterans dental care initiative in Phoenix. The bank is providing a $100,000 charitable donation to help create a dedicated dental program for veterans experiencing housing insecurity. This initiative is intended as a permanent, targeted support program focused on a vulnerable local population. For investors watching Western Alliance Bancorporation at a share price of $67.04, this new veterans...

Starwood Real Estate Income Trust (OTCPK:SWDR) has posted its FY 2025 numbers with fourth quarter revenue of US$402.8 million, a basic EPS loss of US$0.39, and funds from operations of US$4.4 million in the red, setting the tone for a year where trailing twelve month revenue reached about US$1.6 billion alongside a net loss of US$691.6 million. Over recent quarters, revenue has moved in a tight band between US$389.7 million and US$420.2 million while EPS has remained in loss territory. As a...

If you are wondering whether CoreWeave at around US$81.47 offers fair value or a potential opportunity, this article will help you frame that question clearly before you commit fresh capital. The stock is roughly flat over the past week with a 0.4% return, while the 30 day return of a 14.6% decline and the year to date gain of 2.7% indicate that sentiment has shifted recently. Recent headlines have focused on CoreWeave as part of broader discussions about AI infrastructure and cloud related...

If you have been wondering whether Teleflex at around US$105.41 is pricing in too much risk or leaving room for upside, you are not alone. The stock has seen a 1.8% decline over the past week, a 6.3% decline over the last month, and is down 13.9% year to date, with a 24.7% decline over the past year and a 56.6% decline over three years, extending to a 73.6% decline over five years. These moves have put Teleflex firmly on the radar for investors who focus on medical equipment names that have...

Why Banner Stock Is Drawing Attention Now Banner (BANR) is back on investor radars after recent share price pressure, including a return of about a 9% decline over the past month and roughly a 12% decline over the past 3 months. See our latest analysis for Banner. At a share price of US$58.07, Banner’s recent 1 month share price return of a 9.24% decline and year to date share price return of a 7.04% decline contrast with its 3 year total shareholder return of 18.77%. This suggests recent...

Wondering if Vulcan Materials at US$258.40 is priced for opportunity or already expensive? This breakdown focuses squarely on what you are getting for the price you pay. The stock has seen a 2.6% decline over the last 7 days and a 13.7% decline over the last 30 days, even though the 1 year return sits at 11.2% and the 3 year return at 59.0%. Recent coverage has highlighted Vulcan Materials as a key U.S. construction materials supplier, with investors watching how infrastructure spending and...

York Space Systems recently reported full-year 2025 results, with sales rising to US$386.2 million while net loss narrowed to US$84.54 million, and issued 2026 revenue guidance of US$545 million to US$595 million, mostly backed by existing backlog. The company also highlighted that over 70% of its 2026 revenue target at the midpoint is already supported by contracted backlog, while recent acquisitions such as Orbion Space Technology and ATLAS Space Operations aim to strengthen its vertically...

IDT Corporation recently reported past second-quarter fiscal 2026 results showing higher sales and net income year-over-year, alongside improved earnings per share from continuing operations. The board also raised the annual dividend from US$0.24 to US$0.28 per share, signaling confidence in the company’s cash generation and capital return plans. With this dividend increase as a starting point, we’ll now examine how these developments could influence IDT’s broader investment narrative. AI is...

In March 2026, Walgreens announced a nationwide initiative with Exact Sciences and Workflow Services that lets eligible, average-risk customers request the FDA-approved, at-home Cologuard colorectal cancer screening test through its pharmacies, aiming to close care gaps with pharmacist-led services integrated into store workflows. At the same time, Exact Sciences highlighted new data on its Oncodetect molecular residual disease test and Cancerguard multi-cancer early detection assay at the...

If you are wondering whether HealthEquity is attractively priced or if the opportunity has already passed, this article walks through the key numbers that matter for valuation. The stock last closed at US$81.02, with returns of 4.1% over 7 days and 5.1% over 30 days. Year to date the return stands at an 11.0% decline and the 1-year return is a 4.5% decline, compared with a 44.6% gain over 3 years and 15.7% over 5 years. Recent headlines around HealthEquity have focused on its position in...

Taysha Gene Therapies (NasdaqGS:TSHA) received FDA Breakthrough Therapy designation for TSHA-102 in Rett syndrome. The company reported a 100% patient response rate in pivotal Phase I/II data for TSHA-102. Regulators aligned with Taysha on pivotal trial designs for its lead Rett syndrome program. Taysha added a key commercial hire as it prepares for potential TSHA-102 commercialization. Taysha Gene Therapies, trading at $4.4 per share, has been drawing attention as its 1 year return stands...

For investors considering whether Verisk Analytics at around US$201.75 represents fair value or a potential opportunity, this article focuses on what the current price might imply. The stock recently posted a 0.3% return over 7 days and 9.6% over 30 days, while the year-to-date return is an 8.7% decline and the 1-year return is a 28.7% decline. Recent headlines have highlighted Verisk Analytics as a data and analytics provider in the commercial services space, with attention on how its core...

Ambarella (NasdaqGS:AMBA) used a recent industry conference to outline a faster push into Edge AI products. The company highlighted a major shift in its revenue mix, new sales efforts aimed at smaller customers, and progress on a semi custom chip. Management also disclosed work on an upcoming two nanometer chip, signaling a move to more advanced manufacturing nodes. Ambarella, trading at about $54.02, has seen a mixed share price record, with a 3.3% gain over the past week but a 28.1%...

Yiren Digital (YRD) is back in focus after Q4 2025 results showed revenue of CN¥957.63 million, a net loss of CN¥882.16 million, and a temporary suspension of its cash dividend for the second half of 2025. See our latest analysis for Yiren Digital. The earnings miss and dividend suspension appear to have weighed heavily on sentiment, with a 7 day share price return of 44.19% and a 1 year total shareholder return of 69.72%. The 3 year total shareholder return remains slightly positive, which...

Recent analyst commentary on Enovix (ENVX) is highlighting a mix of long term optimism around its high energy density lithium ion batteries, along with caution about manufacturing hurdles, negative margins, and cash burn tied to scaling production. See our latest analysis for Enovix. The share price has been under pressure, with a 1 month share price return showing an 18.32% decline and a year to date share price return showing a 38.40% decline. The 1 year total shareholder return of 42.49%...

What recent performance suggests about Herc Holdings (HRI) Herc Holdings (HRI) has drawn investor attention after a series of weak returns, with the stock down about 3% over the past day, 8% over the past week, and roughly 32% over the past month. See our latest analysis for Herc Holdings. While the recent 1 month share price return of 31.75% and year to date share price return of 34.09% are weak, the 5 year total shareholder return of 9.60% points to a more modest long term outcome. This...

HeartFlow (NasdaqGS:HTFL) reported landmark real world data at ACC 2026 showing its AI Plaque Analysis as a leading independent predictor for cardiovascular risk stratification. The Plaque Analysis data is linked with improved patient outcomes and substantial cost savings in coronary artery disease management. The company launched the large scale NAVIGATE PCI Registry to study its AI driven PCI Navigator tool ahead of commercial release. HeartFlow’s AI platform is now backed by FDA cleared...

If you are wondering whether Global Payments at around US$68.50 represents a bargain or a value trap, this article examines what the current price might be indicating about the stock. The share price has eased by 0.2% over the past week and 15.7% over the last month, contributing to returns of 9.3% lower year to date and 28.5% lower over the past year. Recent headlines around Global Payments have focused on its position within the diversified financials space and how investors are...

Investors may be considering whether Service Corporation International at around US$75.43 still offers value, or if most of the opportunity is already priced in. The stock has recently pulled back, with returns of 5.1% over the last 7 days, 5.9% over the last 30 days, and 2.3% year to date. The 1 year return sits at 1.6%, and the longer term 3 and 5 year returns are 19.3% and 59.3% respectively. Recent coverage has focused on Service Corporation International as an established player in...